BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9857228)

  • 21. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
    Furth PA; St Onge L; Böger H; Gruss P; Gossen M; Kistner A; Bujard H; Hennighausen L
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9302-6. PubMed ID: 7937760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
    Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
    J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REST-VP16 activates multiple neuronal differentiation genes in human NT2 cells.
    Immaneni A; Lawinger P; Zhao Z; Lu W; Rastelli L; Morris JH; Majumder S
    Nucleic Acids Res; 2000 Sep; 28(17):3403-10. PubMed ID: 10954611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters.
    Maxwell IH; Spitzer AL; Long CJ; Maxwell F
    Gene Ther; 1996 Jan; 3(1):28-36. PubMed ID: 8929909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants.
    Jamieson DR; Robinson LH; Daksis JI; Nicholl MJ; Preston CM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1417-31. PubMed ID: 7782770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
    Harms JS; Splitter GA
    Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
    Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
    Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts.
    Kiehntopf M; Herrmann F; Brach MA
    J Exp Med; 1995 Feb; 181(2):793-8. PubMed ID: 7530764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced long-term expression from helper virus-free HSV-1 vectors packaged in the presence of deletions in genes that modulate the function of VP16, U L 46 and U L 47.
    Liu M; Tang J; Wang X; Yang T; Geller AI
    J Neurosci Methods; 2005 Jun; 145(1-2):1-9. PubMed ID: 15922021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
    Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
    Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent enhancement of transcriptional activity and specificity of a retinal pigment epithelial cell-preferential promoter.
    Zhang D; Sutanto EN; Rakoczy PE
    Mol Vis; 2004 Mar; 10():208-14. PubMed ID: 15064682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro search for alternative promoters to the human immediate early cytomegalovirus (IE-cMV) to express the G gene of viral haemorrhagic septicemia virus (VHSV) in fish epithelial cells.
    Ruiz S; Tafalla C; Cuesta A; Estepa A; Coll JM
    Vaccine; 2008 Dec; 26(51):6620-9. PubMed ID: 18840493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong transcriptional activators isolated from viral DNA by the 'activator trap', a novel selection system in mammalian cells.
    Gstaiger M; Schaffner W
    Nucleic Acids Res; 1994 Oct; 22(20):4031-8. PubMed ID: 7937127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.
    Palmer JA; Branston RH; Lilley CE; Robinson MJ; Groutsi F; Smith J; Latchman DS; Coffin RS
    J Virol; 2000 Jun; 74(12):5604-18. PubMed ID: 10823868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific transcriptional targeting of suicide gene therapy.
    Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
    Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
    Yu YA; Szalay AA
    Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of modular and versatile plasmid vectors for the high-level expression of single or multiple genes in insects and insect cell lines.
    Huynh CQ; Zieler H
    J Mol Biol; 1999 Apr; 288(1):13-20. PubMed ID: 10329122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
    Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
    Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.